ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EROX Human Pheromone Sciences Inc (GM)

0.0004
0.00 (0.00%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Human Pheromone Sciences Inc (GM) USOTC:EROX OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0004 0.00 01:00:00

- Termination of Registration of a Class of Security under Section 12(g) (15-12G)

30/03/2012 5:17pm

Edgar (US Regulatory)


 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 000-23544

 

HUMAN PHEROMONE SCIENCES, INC.

(Exact name of registrant as specified in its charter)

 

California   94-3107202
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
     
84 West Santa Clara Street, San Jose, California   95113
(Address of principal executive offices)   (Zip code)

 

Registrant’s telephone number: (408) 938-3030

 

 

Common Stock

(Title of each class of securities covered by this Form)

 

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1) ¨  
Rule 12g-4(a)(2) ¨
Rule 12h-3(b)(1)(i) ¨
Rule 12h-3(b)(1)(ii) x
Rule 15d-6 ¨

 

Approximate number of holders of record as of the certification or notice date:

487

 

 
 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: March 30, 2012 /s / William P. Horgan
  William P. Horgan
  Chairman and Chief Executive Officer
  (Principal Executive Officer)

 

 

 

 

 

1 Year Human Pheromone Sciences (GM) Chart

1 Year Human Pheromone Sciences (GM) Chart

1 Month Human Pheromone Sciences (GM) Chart

1 Month Human Pheromone Sciences (GM) Chart